Harrow HROW
NASDAQ HROW
$37.82 -0.03 (-0.08%)
As of: Sep 9, 2026 · 1:44 PM EDT

Harrow (HROW) Non-Current Debt (2011 - 2026)

Harrow (HROW) posted Non-Current Debt of $292.4 million for Q2 2026, little changed on a QoQ basis from $292.1 million in Q1 2026, and up 659.74% year-over-year from $38.5 million in Q2 2025.

Analysis

Harrow (HROW) Non-Current Debt (2011 - 2026) Analysis & Trends

Harrow has reported Non-Current Debt for 13 years, with the latest figure at $292.4 million in Q2 2026.

  • On a quarterly basis, Non-Current Debt rose 659.74% year-over-year to $292.4 million in Q2 2026; TTM through Jun 2026 was $292.4 million, a 659.74% increase from a year earlier, with the FY2025 full-year figure at $243.2 million, up 10.77% from the prior year.
  • Non-Current Debt was $292.4 million for Q2 2026 at Harrow, roughly flat from $292.1 million in the prior quarter.
  • The five-year high for Non-Current Debt was $292.4 million in Q2 2026, with the low at $38.5 million in Q2 2025.
  • Average Non-Current Debt over 5 years is $168.0 million, with a median of $183.2 million recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Non-Current Debt sank 79.2% in 2025, then surged 659.74% in 2026.
  • Over 5 years, Non-Current Debt stood at $104.2 million in 2022, then surged by 78.44% to $185.9 million in 2023, then rose by 18.1% to $219.5 million in 2024, then advanced by 10.77% to $243.2 million in 2025, then climbed by 20.23% to $292.4 million in 2026.
  • The last three Non-Current Debt figures came in at $292.4 million (Q2 2026), $292.1 million (Q1 2026), and $243.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 37.34 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 62.48 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn -
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 44.19 Bn 44.19 Bn - -
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn -
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn -
10 Harrow 1.41 Bn 1.33 Bn 50.36 Mn 292.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 292.38 Mn
Mar 31, 2026 292.09 Mn
Dec 31, 2025 243.18 Mn
Sep 30, 2025 242.87 Mn
Jun 30, 2025 38.48 Mn
Mar 31, 2025 112.50 Mn
Dec 31, 2024 219.54 Mn
Sep 30, 2024 186.06 Mn
Jun 30, 2024 185.02 Mn
Mar 31, 2024 184.15 Mn
Dec 31, 2023 185.89 Mn
Sep 30, 2023 182.19 Mn
Jun 30, 2023 169.71 Mn
Mar 31, 2023 168.85 Mn
Dec 31, 2022 104.17 Mn
Sep 30, 2022 72.24 Mn
Jun 30, 2022 72.04 Mn
Mar 31, 2022 71.85 Mn
Dec 31, 2021 71.65 Mn
Sep 30, 2021 71.46 Mn